Find your next paid study

~$10 – $1,050

Actual pay is set by the research site.

SurGenTec LLCNCT07784673

Phase 3

An Interventional, Open-Label, Randomized, Multicenter, Phase 3 Study of PF-07248144 Plus Fulvestrant Compared to Investigator's Choice of Therapy in Adult Participants With Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Whose Disease Progressed After Prior CDK4/6 Inhibitor-based Therapy

The purpose of this study is to learn about the safety and effects of the study medicine PF-07248144 when given along with fulvestrant for the possible treatme…

Breast Cancer

~$50 – $2,250

Actual pay is set by the research site.

PfizerNCT07062965

Postpartum ComplicationPostpartumPTSD+6 more

Postpartum Care in the NICU (PeliCaN) for Maternal Wellbeing and Breastfeeding

Parents of infants in the neonatal intensive care unit (NICU) face unique barriers to long-term breastfeeding and lactation. The physical and emotional demands…

Children's Hospital of PhiladelphiaNCT07881731

Actual pay is set by the research site.

Feasibility of the Investigational Nellcor™ Investigational Device During Non-Motion and Walking Motion Conditions in Adult Volunteers

To examine pulse rate and blood oxygen saturation accuracy of the Nellcor™ Investigational Device during non-motion and walking motion conditions in a diverse …

Oxygen Saturation

Medtronic - MITGNCT07234279

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

A Phase 1b/2, Open-label, Multi-center Study to Evaluate the Anti-cancer Activity, Safety and Tolerability of GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig [T-CELL-Redirecting Agent Targeting Human Kallikrein 2 (KLK2)] in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Who Progressed on Previous Novel Hormonal Therapy (NHT) (JET-201)

The purpose of this clinical trial is to evaluate the safety, tolerability, and preliminary anti-cancer activity of GI-102 in combination with pasritamig in ad…

Metastatic Castration-resistant Prostate Cancer (mCRPC)

GI Innovation, Inc.NCT07871435

~$150 – $4,200

Actual pay is set by the research site.

Heart Failure With Preserved Ejection Fraction

A Prospective Randomized Unblinded Study of Ketogenetic Versus Mixed Diet on Exercise Tolerance in Subjects With the Metabolic Phenotype of Heart Failure With Preserved Ejection Fraction

This study is being done to evaluate the effects of a low carbohydrate ketogenic diet (KD) versus a low-fat diet (MD) on exercise tolerance in participants wit…

Ohio State UniversityNCT06081543

Actual pay is set by the research site.

Phase 2

Involved-Station, Intensity-Modulated Post-Operative Radiation Therapy (I²-PORT) for Resected Non-Small Cell Lung Cancer With Residual Mediastinal Adenopathy After Neoadjuvant Therapy (ypN2)

This phase II trial compares the effect of intensity-modulated post-operative radiation therapy (I²-PORT) followed by standard of care therapy (chemotherapy or…

Lung Non-Small Cell Carcinoma

Alliance for Clinical Trials in OncologyNCT07293247

~$75 – $2,000

Actual pay is set by the research site.

Personalized Risk Assessment of Seizures Sensitive to Poor Sleep: a Longitudinal Study Using Wearable Electroencephalography Devices

Epilepsy, a prevalent neurological disorder, affects 40% of patients with uncontrolled seizures despite medications. Sleep disturbance exacerbates epilepsy, an…

Epilepsy Intractable

Duke UniversityNCT06545643

Actual pay is set by the research site.

Evaluation of a Lupus Nephritis Care Pathway Integrating Telemedicine and Clinical Pharmacist Practitioners

The purpose of this study is to evaluate an approach to managing patients with lupus nephritis called the Lupus Nephritis (LN) Pathway among approximately 25 p…

Lupus Nephritis (LN)

Duke UniversityNCT07783152

Actual pay is set by the research site.

Perinatal AnxietyPerinatal Depression

Improving Perinatal Mental Health Among Latinas Through a Culturally Adapted, Multi-Level Intervention

The goal of this clinical trial is to learn if an intervention can improve mental health outcomes among pregnant and postpartum Latinas. The main questions it …

American UniversityNCT07880457

Actual pay is set by the research site.

Phase 1

A Phase 1/2 Open-label First-in-Human Dose-Escalating Safety and Efficacy Study Evaluating Subcutaneous Administration of PTH-IA in Adults and Children With Jansen s Metaphyseal Chondrodysplasia (JMC)

Jansen s Metaphyseal Chondrodysplasia (JMC) is a very rare disorder with only approximately 30 people known to have the disease worldwide. It is caused by para…

Jansen's Metaphyseal Chondrodysplasia

National Institute of Dental and Craniofacial Research (NIDCR)NCT07541209

~$150 – $2,700

Actual pay is set by the research site.

Phase 2

A Parallel-group Treatment, Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Umbrella Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, and Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

This is a parallel, Phase 2a, double-blind, 6-arm study for the treatment of primary focal segmental glomerulosclerosis (FSGS) or minimal change disease (MCD).…

Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion